Patients with AF had a higher prevalence of using cardiovascular medications such as angiotensin-converting enzyme inhibitors (ACEIs) (24.3% vs. 10.5%, p < 0.001), angiotensin II receptor blockers (ARBs) (37.4% vs. 24.2%, p = 0.002), anticoagulants (66.1% vs. 2.4%, p < 0.001), and diuretics (45.2% vs. 9.3%, p < 0.001). Here, ACE is linked to atrial fibrillation.